Therapeutic Plasma Exchange in Patients With Acute‐On‐Chronic Liver Failure Improves Survival—An Updated Meta‐Analysis
Liver International · 2025-05 · 45 (5)
DOI: 10.1111/liv.70018 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Liver International, online erschienen am 23.04.2025. Verfasst von Santhosh E Kumar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Christian Medical College, Vellore, India. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Plasma Exchange. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Acute‐on‐chronic liver failure (ACLF) is a syndrome that develops after an acute insult and is associated with organ failures and high short‐term mortality. Plasma exchange (PLEX) is an emerging modality for treating ACLF patients. We aimed to evaluate the efficacy of PLEX in treating ACLF.
Methods
We conducted a systematic review and meta‐analysis of studies comparing PLEX versus standard medical therapy (SMT) to treat patients with ACLF across different definitions and etiologies. Pooled risk ratios were determined by the Mantel–Haenszel method within a random effect model. The primary outcome studied was survival at 30 days in PLEX group compared to SMT.
Results
Twenty‐three studies (5336 ACLF patients with 2724 in PLEX arm, including 4 RCTs) were included. PLEX was associated with a significant reduction in mortality at 30 days (RR 0.70; 95% CI, 0.60–0.81; p < 0.001) and at 90 days (RR 0.81;0.77–0.86; p < 0.001). Six studies (1495 patients; 2 RCTs) with data for 1‐year survival showed better outcomes in the PLEX group (RR 0.85; 0.79–0.92; p < 0.0001) compared to SMT. Among HBV‐related ACLF and alcohol‐related ACLF, there was a significant reduction in mortality among PLEX treated group at 90 days; RR 0.79 (0.74–0.85), p < 0.001 and RR 0.69 (0.52–0.92), p = 0.01 respectively. PLEX was associated with improved 3‐month survival across definitions for ACLF. The most common adverse effects were skin rash and allergic reactions (14%).
Conclusions
In this up‐to‐date meta‐analysis, significant 1, 3‐month and up to 1‐year survival benefit was noted among patients with ACLF treated with PLEX compared to SMT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatology, Christian Medical College, Vellore, India.
- Department of Physiology, University of Jaffna, Jaffna, Sri Lanka.
- Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
- Department of Internal Medicine B, University of Münster, Münster, Germany; European Foundation for the Study of Chronic Liver Failure, EF CLIF, Barcelona, Spain.
- Division of Gastroenterology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
ORCID-Profile: Santhosh E Kumar, Jonel Trebicka, Constantine J Karvellas, Ashish Goel
Zitieren
APA
Kumar, S. E., Sithamparapillai, K., Choudhury, A. K., Bharadwaj, P. K., Trebicka, J., Karvellas, C. J., Arab, J. P., Premkumar, P. S., Eapen, C. E., & Goel, A. (2025). Therapeutic Plasma Exchange in Patients With Acute‐On‐Chronic Liver Failure Improves Survival—An Updated Meta‐Analysis. Liver International, 45(5). https://doi.org/10.1111/liv.70018
Vancouver
Kumar SE, Sithamparapillai K, Choudhury AK, Bharadwaj PK, Trebicka J, Karvellas CJ, et al. Therapeutic Plasma Exchange in Patients With Acute‐On‐Chronic Liver Failure Improves Survival—An Updated Meta‐Analysis. Liver International. 2025;45(5). doi:10.1111/liv.70018
BibTeX
@article{Kumar2025,
author = {Kumar, Santhosh E and Sithamparapillai, Kausala and Choudhury, Ashok Kumar and Bharadwaj, P Krishna and Trebicka, Jonel and Karvellas, Constantine J and Arab, Juan Pablo and Premkumar, Prasanna Samuel and Eapen, C E and Goel, Ashish},
title = {Therapeutic Plasma Exchange in Patients With Acute‐On‐Chronic Liver Failure Improves Survival—An Updated Meta‐Analysis},
journal = {Liver International},
year = {2025},
volume = {45},
number = {5},
doi = {10.1111/liv.70018}
}
EUVIMED